- Home
- MHF vs FBRX Comparison
MHF vs FBRX Comparison
Compare MHF & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHF
- FBRX
- Stock Information
- Founded
- MHF 1988
- FBRX N/A
- Country
- MHF United States
- FBRX United States
- Employees
- MHF N/A
- FBRX N/A
- Industry
- MHF Finance/Investors Services
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- MHF Finance
- FBRX Health Care
- Exchange
- MHF Nasdaq
- FBRX Nasdaq
- Market Cap
- MHF 150.0M
- FBRX 125.9M
- IPO Year
- MHF N/A
- FBRX N/A
- Fundamental
- Price
- MHF $7.03
- FBRX $15.60
- Analyst Decision
- MHF
- FBRX Strong Buy
- Analyst Count
- MHF 0
- FBRX 3
- Target Price
- MHF N/A
- FBRX $77.58
- AVG Volume (30 Days)
- MHF 57.2K
- FBRX 61.1K
- Earning Date
- MHF 01-01-0001
- FBRX 11-14-2024
- Dividend Yield
- MHF 4.29%
- FBRX N/A
- EPS Growth
- MHF N/A
- FBRX N/A
- EPS
- MHF N/A
- FBRX N/A
- Revenue
- MHF N/A
- FBRX N/A
- Revenue This Year
- MHF N/A
- FBRX N/A
- Revenue Next Year
- MHF N/A
- FBRX N/A
- P/E Ratio
- MHF N/A
- FBRX N/A
- Revenue Growth
- MHF N/A
- FBRX N/A
- 52 Week Low
- MHF $5.92
- FBRX $4.11
- 52 Week High
- MHF $6.79
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- MHF 53.70
- FBRX 41.07
- Support Level
- MHF $6.88
- FBRX $13.82
- Resistance Level
- MHF $7.00
- FBRX $17.81
- Average True Range (ATR)
- MHF 0.12
- FBRX 2.82
- MACD
- MHF 0.02
- FBRX -1.02
- Stochastic Oscillator
- MHF 75.68
- FBRX 14.65
About MHF Western Asset Municipal High Income Fund Inc.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).